Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × ABTL0812 × Clear all

Phase

Status

Completed 2 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Specimen Handling 31 Magnetic Resonance Spectroscopy 21 Cyclophosphamide 17 Biopsy 16 Vincristine 9 Nivolumab 9 Doxorubicin 9 Cisplatin 9 Prednisone 8 Paclitaxel 8 Bevacizumab 8 Gemcitabine 7 pembrolizumab 6 Rituximab 6 Etoposide 6 Drug Therapy 6 Docetaxel 6 Carboplatin 6 Radiotherapy 5 Radiosurgery 5 Fluorouracil 5 Capecitabine 5 venetoclax 4 prednylidene 4 fludarabine 4 durvalumab 4 deltacortene 4 atezolizumab 4 S 1 (combination) 4 Radiation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03417921 2025-10-01

Pancreatic

Ability Pharmaceuticals SL

Phase 1/2 Suspended

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡